In these states, an experienced PMHNP could prescribe GLP-1s or other weight-loss medications on their own, provided: Examples of FPA states (as of 2026): Arizona, Colorado, Connecticut, Hawaii, Idaho, Iowa, Maine, Maryland, Montana, Nebraska, Nevada, New Hampshire, New Mexico, North Dakota, Oregon, Rhode Island, Washington, Wyoming, and soon California (phased in 2023-2026)
Dose adjustments of these agents are likely to be necessary under medical supervision
The drug's half-life (the time it takes for half the dose to leave your system) is approximately seven days
Dosage The dosage of semaglutide GLP-1 can impact how quickly it takes effect
Mol Metab 46:101139 Willard FS, Douros JD, Gabe MB, Showalter AD, Wainscott DB, Suter TM et al (2020) Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist
Third-Party Tested Public COAs Batch Verified EU Shipping Related Products 49,00 49,00